Status:

COMPLETED

Comparison of Tramadol vs Remifentanyl Patient Controlled Analgesia for Second Trimester Abortions

Lead Sponsor:

Rabin Medical Center

Conditions:

Abortion,Induced

Eligibility:

FEMALE

18-50 years

Phase:

NA

Brief Summary

Patients undergoing second trimester abortions will recieve either patient controlled analgesia with either remifentanyl or tramadol for pain alleviation. We beleive both to be equally effective for ...

Detailed Description

Women undergoing second trimester abortions will recieve patient controlled analgesia eith either tramadol or remifentanyl. Patients will not know what they are recieving. Patients in the tramadol g...

Eligibility Criteria

Inclusion

  • Woman undergoing 2nd trimester abortion -

Exclusion

  • Seizure disorder
  • \- \* Psychiatric disorder
  • Inability to recieve patient controlled analgesia
  • Allergy to tramadol or remifentanyl

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2007

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00361686

Start Date

January 1 2006

End Date

January 1 2007

Last Update

November 24 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rabin Medical Center

Petach Tiqvah, Israel